Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ImmunityBio, Inc. Director's Dealing 2021

Feb 10, 2021

31529_dirs_2021-02-09_2a9bb6d4-7b6d-4dfd-98f4-27203586e7a0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2021-02-05

Reporting Person: Adcock Richard (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-05 Common Stock M 150000 $0.00 Acquired 150000 Direct
2021-02-05 Common Stock F 68171 $23.72 Disposed 81829 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-05 Stock Option (right to buy) $23.72 A 750000 Acquired 2031-02-05 Common Stock (750000) Direct
2021-02-05 Restricted Stock Units $ A 250000 Acquired Common Stock (250000) Direct
2021-02-05 Restricted Stock Units $ A 150000 Acquired Common Stock (150000) Direct
2021-02-05 Restricted Stock Units $ M 150000 Disposed Common Stock (150000) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock.

F2: Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option shall vest in equal annual installments on each of the first, second and third anniversaries of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 5, 2021.

F3: Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021.

F4: One hundred percent (100%) of the shares subject to the RSU award shall vest on the date of grant.